HIV / AIDS in the News

Weekly Oral HIV Treatment Continues to Look Promising - POZ

 

Nashville Health Dept.: Some Vanderbilt patients may have been exposed to HIV, hepatitis - Tennessean

 

Dr. Kimberly Smith talks about the HIV epidemic - WTVM

 

Winnie Byanyima, from UNAIDS: ‘Lenacapavir is more effective than condoms or PrEP in prevention’ - EL PAÍS USA

 

Celebrating American Pharmacists Month - HIV.gov

 

Digital Desk: Ending HIV epidemic - Action News 5

 

Infectious Disease Incidence in Individuals with HIV Following K-Tx - Physician's Weekly

 

How the Mpox Response Has Learned from History - Nature.com

 

Vall d'Hebron identifies one of the mechanisms that allows HIV control without treatment - Vall d'Hebron Barcelona Hospital Campus

 

IDWeek 2024: Prevention and treatment for HIV – clinical trials and policy challenges - Yahoo Finance

 

IDWeek 2024: Prevention and treatment for HIV – clinical trials and policy challenges - Clinical Trials Arena

 

Why a fortunate few don’t get ill after HIV infection - Nature.com

 

Multicenter clinical trial shows HIV-to-HIV kidney transplants to be safe, effective - Emory News Center

 

Hep C and HIV testing in Greenville - The Daily Advocate

 

Cambodia’s HIV authorities seek out undiagnosed people living with illness - asianews.network

 

Educational Initiatives Boost Women’s HIV Awareness, PrEP Uptake | IDWeek 2024 - Drug Topics

 

Brave New Name - How PCP Became PJP and Why It Matters - HIV and ID Observations - NEJM Journal Watch Medical Blogs

 

Gilead and MSD to advance once-weekly HIV treatment to Phase III - Yahoo Finance

 

Student Rec to host free HIV/STI testing - bgfalconmedia.com

 

HIV Then and Now: The Power of Innovation - WJTV

 

Gilead and MSD to advance once-weekly HIV treatment to Phase III - Clinical Trials Arena

 

“I Am the Face of AIDS”: Ryan White and the Politics of Innocence in the History of HIV/AIDS - Public Books

 

Loss of HIV candidate vaccine efficacy in male macaques by mucosal nanoparticle immunization rescued by V2-specific response - Nature.com

 

New Rule: Insurers Must Cover Daily and Long-Acting PrEP to Prevent HIV - POZ

 

Success of long-lasting HIV drug hinges on pricing - Medical Xpress

 

HIV Preexposure Prophylaxis Use Increased in Recent Years - Renal and Urology News

 

HIV infection in six transplant patients in Brazil points to nepotism and greed of a laboratory - EL PAÍS USA

 

Funding Opportunity Announcement for DoD DHAPP PEPFAR program | Closing: 12pm EST on December 6, 2024 - US Embassy in Uganda - USEmbassy.gov

 

Study: Kidney transplants safe between HIV patients - Temple Daily Telegram

 

LGBTQ Agenda: Biden administration expands injectable PrEP coverage - Bay Area Reporter, America's highest circulation LGBT newspaper